Myovant On Path To Women’s Health Leadership, CEO Says

CEO Lynn Seely talked during a fireside chat at the BIO CEO & Investor meeting about her company’s strategy to build a new women’s health company and even best big pharma rivals.

business

More from Immunological

More from Therapy Areas